The Metabolic Basis of Vascular Disease: A Translational Journey is organized by University Hospitals Cleveland Medical Center (UHCMC) and will be held during Mar 09, 2017 - Mar 08, 2020.
The target audience for this medical event is physicians, surgeons and other members of the health care team. Most presentations will benefit primary care physicians in clinical practice. Office managers and administrators may also benefit from awareness and discussion of clinical initiatives and quality management issues. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.
Conference Objectives are : -
• Recognize the fundamental role of metabolism and mitochondria in the proliferative/anti-apoptotic phenotype of vascular cells in vascular remodeling.
• Discuss the “Metabolic Theory” of Pulmonary Arterial Hypertension (PAH) and the challenges of translational research in the field.
• Describe the progression from preclinical research to applied clinical research and early-phase trials in PAH; and the role of Precision Medicine in the design of future trials in vascular medicine and PAH.
To receive a statement of credit for up to 1.00 AMA PRA Category 1 Credits, you must:
• Review and reflect on the full content of the recorded session.
• Successfully complete the post-test. A score of 75% is required for passage.
• Complete the evaluation.
There is no fee for this program.
Additional details will be posted as soon as they are available.